Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Chemoradiotherapy for squamous cell cancer of the anal canal: a systematic review.

Spithoff K, Cummings B, Jonker D, Biagi JJ; Gastrointestinal Cancer Disease Site Group.

Clin Oncol (R Coll Radiol). 2014 Aug;26(8):473-87. doi: 10.1016/j.clon.2014.03.005. Epub 2014 Apr 8. Review.

PMID:
24721444
2.

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG.

J Clin Oncol. 2012 Dec 10;30(35):4344-51. doi: 10.1200/JCO.2012.43.8085. Epub 2012 Nov 13.

3.

Anal carcinoma therapy: can we improve on 5-fluorouracil/mitomycin/radiotherapy?

Jiang Y, Mackley H, Cheng H, Ajani JA.

J Natl Compr Canc Netw. 2010 Jan;8(1):135-44. Review.

PMID:
20064295
5.
6.

Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.

Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH.

Cancer. 2013 Nov 1;119(21):3769-75. doi: 10.1002/cncr.28296. Epub 2013 Aug 20.

7.

Review of anal cancer patients at the Ottawa hospital.

Abunassar M, Reinders J, Jonker DJ, Asmis T.

Eur J Surg Oncol. 2015 May;41(5):653-8. doi: 10.1016/j.ejso.2015.02.004. Epub 2015 Mar 4.

PMID:
25776438
8.

Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).

Matzinger O, Roelofsen F, Mineur L, Koswig S, Van Der Steen-Banasik EM, Van Houtte P, Haustermans K, Radosevic-Jelic L, Mueller RP, Maingon P, Collette L, Bosset JF; EORTC Radiation Oncology and Gastrointestinal Tract Cancer Groups.

Eur J Cancer. 2009 Nov;45(16):2782-91. doi: 10.1016/j.ejca.2009.06.020. Epub 2009 Jul 28.

PMID:
19643599
9.

Chemoradiotherapy for squamous cell carcinoma of the anal canal: Comparison of one versus two cycles mitomycin-C.

White EC, Goldman K, Aleshin A, Lien WW, Rao AR.

Radiother Oncol. 2015 Nov;117(2):240-5. doi: 10.1016/j.radonc.2015.08.015. Epub 2015 Sep 4.

PMID:
26347494
10.

Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.

Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ.

J Clin Oncol. 2007 Oct 10;25(29):4581-6. Erratum in: J Clin Oncol. 2008 Feb 1;26(4):694.

PMID:
17925552
11.

Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial.

Glynne-Jones R, Kadalayil L, Meadows HM, Cunningham D, Samuel L, Geh JI, Lowdell C, James R, Beare S, Begum R, Ledermann JA, Sebag-Montefiore D; ACT II Study Group.

Ann Oncol. 2014 Aug;25(8):1616-22. doi: 10.1093/annonc/mdu188. Epub 2014 May 14.

PMID:
24827136
12.

Shifting paradigm in the management of anal canal carcinoma.

Mallick S, Benson R, Julka PK, Rath GK.

J Gastrointest Cancer. 2015 Mar;46(1):1-4. doi: 10.1007/s12029-014-9673-0. Review.

PMID:
25432583
13.

[Chemoradiotherapy and anal canal cancer].

Ortholan C, François E, Gérard JP.

Bull Cancer. 2005 Dec;92(12):1039-47. French.

14.

Combined-modality treatment for anal cancer: current strategies and future directions.

Fraunholz I, Rabeneck D, Weiss C, Rödel C.

Strahlenther Onkol. 2010 Jul;186(7):361-6. doi: 10.1007/s00066-010-2162-x. Epub 2010 Jun 24. Review.

PMID:
20582392
15.

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma.

Zampino MG, Magni E, Leonardi MC, Santoro L, Petazzi E, Fodor C, Petralia G, Trovato C, Nolè F, Orecchia R.

BMC Cancer. 2011 Feb 3;11:55. doi: 10.1186/1471-2407-11-55.

16.

Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.

Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, Feig B, Skibber J, Janjan N.

Cancer. 2003 Mar 1;97(5):1195-202.

17.

[Radiochemotherapy in anal canal epidermoid cancer].

Peiffert D.

Ann Chir. 2000 Oct;125(8):717-25. Review. French.

PMID:
11105342
18.

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients.

Cho BC, Ahn JB, Seong J, Roh JK, Kim JH, Chung HC, Sohn JH, Kim NK.

BMC Cancer. 2008 Jan 15;8:8. doi: 10.1186/1471-2407-8-8.

19.

Management of anal cancer in 2010. Part 2: current treatment standards and future directions.

Abbas A, Yang G, Fakih M.

Oncology (Williston Park). 2010 Apr 30;24(5):417-24. Review.

20.

Mitomycin-C- or cisplatin-based chemoradiotherapy for anal canal carcinoma: long-term results.

Olivatto LO, Cabral V, Rosa A, Bezerra M, Santarem E, Fassizoli A, Castro L, Simões JH, Small IA, Ferreira CG.

Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):490-5. doi: 10.1016/j.ijrobp.2009.11.057. Epub 2010 May 14.

PMID:
20472349

Supplemental Content

Support Center